Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Deloitte
Moodys
Covington
Medtronic
Citi
Accenture
Farmers Insurance

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,817,338

« Back to Dashboard

Summary for Patent: 5,817,338
Title: Multiple unit tableted dosage form of omeprazole
Abstract:A new pharmaceutical multiple unit tableted dosage form containing omeprazole or one of its single enantiomers or an alkaline salt of omeprazole or one of its single enantiomers, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Inventor(s): Bergstrand; Pontus John Arvid (Goteborg, SE), Lovgren; Kurt Ingmar (Molndal, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/454,395
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,817,338
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Compound; Process;

Drugs Protected by US Patent 5,817,338

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,817,338

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9402432Jul 08, 1994
Sweden9402433Jul 08, 1994
PCT Information
PCT FiledJune 07, 1995PCT Application Number:PCT/SE95/00677
PCT Publication Date:January 25, 1996PCT Publication Number: WO96/01623

International Family Members for US Patent 5,817,338

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary T75775 ➤ Try a Free Trial
Finland 961057 ➤ Try a Free Trial
Canada 2170647 ➤ Try a Free Trial
China 1134666 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Moodys
Boehringer Ingelheim
Cantor Fitzgerald
Healthtrust
Cerilliant
Deloitte
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.